http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-19990063788-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-728 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 |
| filingDate | 1996-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1999-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-19990063788-A |
| titleOfInvention | How to use hyaluronic acid as an immunosuppressant |
| abstract | The present invention relates to the administration of a pharmaceutical formulation of hyaluronic acid to a patient suffering from undesirable T cell activity. Hyaluronic acid inhibits T cell activation at doses with good resistance to receptors. Diseases suitable for treatment include graft versus host disease, graft rejection and certain autoimmune diseases with T cells. |
| priorityDate | 1995-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 322.